扬子江药业集团江苏制药股份有限公司
Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
46
NMPA:46
Drug Approvals
Terbinafine Hydrochloride Cream
- Product Name
- 盐酸特比萘芬乳膏
- Approval Number
- 国药准字H20083451
- Approval Date
- Nov 21, 2022
NMPA
Ambroxol Hydrochloride Syrup
- Product Name
- 盐酸氨溴索糖浆
- Approval Number
- 国药准字H20083322
- Approval Date
- Nov 21, 2022
NMPA
Memantine Hydrochloride Oral Solution
- Product Name
- 盐酸美金刚口服溶液
- Approval Number
- 国药准字H20223567
- Approval Date
- Aug 10, 2022
NMPA
Levocetirizine Dihydrochloride Oral Solution
- Product Name
- 盐酸左西替利嗪口服溶液
- Approval Number
- 国药准字H20223535
- Approval Date
- Jul 26, 2022
NMPA
Entecavir Oral Solution
- Product Name
- 恩替卡韦口服溶液
- Approval Number
- 国药准字H20203583
- Approval Date
- Nov 17, 2020
NMPA
- Prev
- 1
- 2
- 3
- 4
- 5
- Next
Clinical Trials
No trials found
News
No news found